These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10932464)

  • 21. Retrospective drug utilization review software systems: perspectives of state Medicaid DUR directors.
    Armstrong EP; Proteau D
    Ann Pharmacother; 1996 Oct; 30(10):1088-91. PubMed ID: 8893113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-of-care testing: an introduction.
    Gutierres SL; Welty TE
    Ann Pharmacother; 2004 Jan; 38(1):119-25. PubMed ID: 14742805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of outcomes evaluations applied to drug management programs.
    McAdam-Marx C; Schaaf DT; Holtorf AP; Eng B; Oderda GM
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP36-45. PubMed ID: 18991480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Care management interventions for older patients with congestive heart failure.
    Windham BG; Bennett RG; Gottlieb S
    Am J Manag Care; 2003 Jun; 9(6):447-59; quiz 460-1. PubMed ID: 12816174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-use review and risk management.
    Keys PW
    Am J Hosp Pharm; 1981 Oct; 38(10):1533-4. PubMed ID: 7294055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
    Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
    J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of drug usage review on drug utilisation.
    Blackburn JL
    Pharmacoeconomics; 1993 Jan; 3(1):14-21. PubMed ID: 10146984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DUR: good systems provide assistance, not annoyance.
    Winckler SC
    J Am Pharm Assoc (Wash); 2000; 40(4):462-3. PubMed ID: 10932453
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug use review: operational definitions.
    Stolar MH
    Am J Hosp Pharm; 1978 Jan; 35(1):76-8. PubMed ID: 623123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of prospective drug utilization review.
    Fulda TR; Lyles A; Pugh MC; Christensen DB
    J Manag Care Pharm; 2004; 10(5):433-41. PubMed ID: 15369426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-line DUR messages: pharmacists' attitudes and actions in response.
    Armstrong EP; Markson TJ
    J Am Pharm Assoc (Wash); 1997; NS37(3):315-20. PubMed ID: 9170808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the introduction of a nationwide DUR system where local DUR systems are operating--The Korean experience.
    Yang JH; Kim M; Park YT; Lee EK; Jung CY; Kim S
    Int J Med Inform; 2015 Nov; 84(11):912-9. PubMed ID: 26363001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicaid drug utilization review annual reports for federal fiscal year 1999: looking back to move forward.
    Fulda TR; Collins T; Kuhle J; Devereaux DS; Zuckerman IH
    J Am Pharm Assoc (2003); 2004; 44(1):69-74. PubMed ID: 14965156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edmonton Quality Assessment Tool for Drug Utilization Reviews: EQUATDUR-2: the development of a scale to assess the methodological quality of a drug utilization review.
    Spooner CH; Pickard AS; Menon D
    Med Care; 2000 Sep; 38(9):948-58. PubMed ID: 10982116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost effectiveness of drug utilisation review in an outpatient setting.
    Kreling DH; Mott DA
    Pharmacoeconomics; 1993 Dec; 4(6):414-36. PubMed ID: 10146909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line prescribing: keystrokes for quality.
    Peterson C
    HMO; 1995; 36(5):11-4. PubMed ID: 10153122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creating an appropriate climate for drug use review.
    Tremblay J
    Am J Hosp Pharm; 1981 Feb; 38(2):212-5. PubMed ID: 7211884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.